{
    "clinical_study": {
        "@rank": "122841", 
        "acronym": "Custodiol-AV", 
        "arm_group": [
            {
                "arm_group_label": "Custodiol-N", 
                "arm_group_type": "Experimental", 
                "description": "comparison of two cardioplegic solutions, Custodiol-N versus Custodiol, in aortic valve surgery"
            }, 
            {
                "arm_group_label": "Custodiol", 
                "arm_group_type": "Active Comparator", 
                "description": "comparison of two cardioplegic solutions, Custodiol-N versus Custodiol, in aortic valve surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this investigation is to compare the cardioprotective effects and safety of\n      two cardioplegic solutions, HTK Cardioplegic Solution (Custodiol) and Custodiol-N in\n      patients undergoing aortic valve surgery. The study design is a prospective, double blind,\n      multicenter, randomized, Phase III comparison study intended to demonstrate superiority in\n      surgical outcome between Custodiol and Custodiol-N as determined by CK-MB peak value 4-24\n      hours after opening of the aortic cross-clamp (primary endpoint), catecholamine requirement\n      (cumulative dose) and cardiac Troponin T, occurrence of comorbid events postoperatively\n      (e.g., myocardial infarction)."
        }, 
        "brief_title": "Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Aortic Valve Disease", 
            "Coronary Artery Disease (CAD)"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients >/= 30 and </= 85 years of age\n\n          -  Male or female with aortic valve disease\n\n          -  Able to understand character and individual consequences of the clinical trial and to\n             provide written informed consent to participate in the study\n\n          -  Women of childbearing potential (ie, those who have not undergone a hysterectomy or\n             who have not been post-menopausal for at least 12 consecutive months) must test\n             negative for pregnancy prior to bypass surgery.\n\n        Exclusion Criteria:\n\n          -  History of recent (< 6 weeks) Q-wave myocardial infarction\n\n          -  Left ventricular ejection fraction < 25% (as assessed by any one of the following:\n             contrast ventriculography, multigated acquisition scanning [MUGA], or 2-D ECHO)\n\n          -  Patients on intra-aortic balloon devices or with history of previous coronary artery\n             bypass surgery\n\n          -  Pregnant or lactating patients\n\n          -  Patients who have participated in any other investigational studies within 30 days\n             previous to enrollment\n\n          -  Patients in cardiogenic shock (defined as a systolic BP < 90 mmHg for over one hour\n             despite inotropic and chronotropic support)\n\n          -  Patients with severe chronic obstructive lung disease (FEV1 < 50%)\n\n          -  Previous cardiac valvular disease (clinical relevant)\n\n          -  GFR <60 ml/min\n\n          -  Planned Ross-procedure, Mitral valve surgery, Aortic valve reconstruction, double\n             valve surgery, other concomitant operations excluding coronary artery bypass surgery\n             or closing a patent foramen ovale\n\n          -  Evidence of severe organic (e.g. cirrhosis of the liver) or psychiatric disease by\n             history or physical examination\n\n          -  History of alcohol abuse, illicit drug use, significant mental illness, physical\n             dependence to any opioid, or any history of drug abuse or addiction within 12 months\n             of study enrollment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "437", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02098772", 
            "org_study_id": "CL-N-CSM-AV-III/05/12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Custodiol-N", 
                "description": "comparison of two cardioplegic solutions, Custodiol-N versus Custodiol, in aortic valve surgery", 
                "intervention_name": "Custodiol-N", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Custodiol", 
                "description": "comparison of two cardioplegic solutions, Custodiol-N versus Custodiol, in aortic valve surgery", 
                "intervention_name": "Custodiol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Cardioplegic Solutions"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "aortic valve disease", 
            "coronary bypass surgery", 
            "cardioplegic solutions"
        ], 
        "lastchanged_date": "March 25, 2014", 
        "location": [
            {
                "contact": {
                    "email": "fl.wagner@uke.de", 
                    "last_name": "Florian Wagner, Dr. med.", 
                    "phone": "040 74105 8949"
                }, 
                "contact_backup": {
                    "last_name": "Johannes Schirmer, Dr. med."
                }, 
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20246"
                    }, 
                    "name": "Klinik f\u00fcr Gef\u00e4\u00dfchirurgie, Universit\u00e4res Herzzentrum am UKE Hamburg"
                }, 
                "investigator": [
                    {
                        "last_name": "Florian Wagner, Dr. med.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Johannes Schirmer, Dr. med.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "A.Rastan@hkz-rotenburg.de", 
                    "last_name": "Ardawan Rastan, Dr. med.", 
                    "phone": "06623 88 5858"
                }, 
                "contact_backup": {
                    "email": "j.graff@hkz-rotenburg.de", 
                    "last_name": "J\u00fcrgen Graff, Dr. med.", 
                    "phone": "06623 88 5855"
                }, 
                "facility": {
                    "address": {
                        "city": "Rotenburg an der Fulda", 
                        "country": "Germany", 
                        "zip": "36199"
                    }, 
                    "name": "Klinik f\u00fcr Herz- und Gef\u00e4\u00df-chirurgie GmbH, Herz-Kreislauf-Zentrum Rotenburg"
                }, 
                "investigator": [
                    {
                        "last_name": "Ardawan Rastan, Dr. med.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "J\u00fcrgen Graff, Dr. med.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Double Blind Multicenter Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol", 
        "other_outcome": {
            "description": "documentation and reporting of AE and SAE", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "from time of the study inclusion up to the follow-up visit on day 5"
        }, 
        "overall_official": {
            "affiliation": "Department of Cardiac Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg", 
            "last_name": "Gabor Szab\u00f3, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "peak value for CK-MB", 
            "safety_issue": "No", 
            "time_frame": "measured at  4, 8, 12, 16, 20 and 24 hours after the release of the aortic cross clamp"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02098772"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Catecholamine requirement on SICU", 
            "safety_issue": "No", 
            "time_frame": "within 24 hours (cumulative dose)"
        }, 
        "source": "Dr. F. K\u00f6hler Chemie GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. F. K\u00f6hler Chemie GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}